105 related articles for article (PubMed ID: 3690541)
1. Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Roberts JA; Blessing JA; McGehee R; Beecham J; Homesley HD
Cancer Treat Rep; 1987 Dec; 71(12):1295-6. PubMed ID: 3690541
[No Abstract] [Full Text] [Related]
2. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the cervix.
Bond WH; Arthur K; Banks AJ; Freeman WE; Holme GM; Newsholme GA; Ward HW; Jones WG; Chowdhury MS; Brown I
Clin Oncol; 1976 Jun; 2(2):173-8. PubMed ID: 60188
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Barrett RJ; Gallup DG
Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Homesley HD
Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456
[No Abstract] [Full Text] [Related]
7. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
[No Abstract] [Full Text] [Related]
8. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
[No Abstract] [Full Text] [Related]
9. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Muderspach LI; Blessing JA; Levenback C; Moore JL
Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
[TBL] [Abstract][Full Text] [Related]
10. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Stehman FB; Malfetano J
Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494
[No Abstract] [Full Text] [Related]
11. Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Yazigi R; Yordan E
Cancer Treat Rep; 1987 Sep; 71(9):873-4. PubMed ID: 3621222
[No Abstract] [Full Text] [Related]
12. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
14. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
Bookman MA; Blessing JA; Hanjani P; Herzog TJ; Andersen WA
Gynecol Oncol; 2000 Jun; 77(3):446-9. PubMed ID: 10831357
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
Thigpen T; Blessing JA; Gallup DG; Maiman M; Soper JT
Gynecol Oncol; 1995 Jun; 57(3):376-9. PubMed ID: 7774841
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
Arseneau JC; Bundy B; Dolan T; Homesley H; DiSaia PJ
Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.
Slavik M; Muss H; Blessing JA
Cancer Treat Rep; 1983 Feb; 67(2):195-6. PubMed ID: 6297730
[No Abstract] [Full Text] [Related]
19. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Morris M; Blessing JA; Monk BJ; McGehee R; Moore DH
J Clin Oncol; 2004 Aug; 22(16):3340-4. PubMed ID: 15310778
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus.
Bajorin D; Kelsen D; Heelan R
Cancer Treat Rep; 1986 Oct; 70(10):1245-6. PubMed ID: 3530454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
